首页|医疗机构静脉用细胞毒性药物调配质量管理工作规范(第二版)

医疗机构静脉用细胞毒性药物调配质量管理工作规范(第二版)

扫码查看
为了规范医疗机构静脉用药调配中心细胞毒性药物的调配操作,加强工作人员职业防护,由中国药学会发起,由中国药学会静脉用药调配管理专业委员会联合中国药学会医院药学专业委员会在前期工作基础上,参考现行法律法规、国家标准、行业标准、指导性文件,组织专家对《医疗机构静脉用细胞毒性药物调配质量管理工作规范》进行修订。该规范进一步明确了静脉用细胞毒性药物调配质量管理的总则、一般性要求、安全操作、质量监督和溢出管理等内容,适用于医疗机构静脉用细胞毒性药物调配质量管理工作。
Standard of Quality Management for Cytotoxic Drugs Compounding in Healthcare Institutions(the Second Edition)
To standardize the dispensing operations of cytotoxic drugs in the pharmacy intravenous admixture services(PIVAS)of medical institutions and strengthen the occupational protection of medical practitioners,the Professional Committee of Intravenous Drug Formulation Management the Chinese Pharmaceutical Association jointly with the Hospital Pharmacy Professional Committee of the Chinese Pharmaceutical Association,to revise ihe standard according to current laws and regulations,national standards,industry standards,and guidance documents.This included incorporating newly released relevant documents and materials,and organizing experts to revise the Standard of Quality Management for Cytotoxic Drugs Compounding in Healthcare Institutions.This project further regulates the general principles,general requirements,safe operation,quality supervision,spill management,and other aspects of quality management for intravenous cytotoxic drugs compounding,which applies to the quality management of intravenous cytotoxic drugs compounding in medical institutions.

Cytotoxic drugsCompounding proceduresSpill managementWork standards

中国药学会静脉用药调配管理专业委员会、中国药学会医院药学专业委员会、董占军、刘东

展开 >

细胞毒性药物 调配操作 溢出管理 工作规范

2025

医药导报
中国药理学会 华中科技大学同济医学院附属同济医院 中国医药商业协会

医药导报

北大核心
影响因子:1.042
ISSN:1004-0781
年,卷(期):2025.44(1)